• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    U

    University of Oklahoma Medical Center

    院校EST. 1910
    484论文总数
    1.3万引用总数

    论文量&引用量时间轴

    机构学者

    论文(484)

    年份
    起
    –
    止
    排序
    1Intrawound Tobramycin Plus Vancomycin to Prevent Surgical Site Infection in Tibial Fractures
    Robert V. O’Toole,Nathan N. O’Hara,Anthony R. Carlini,Gregory M. Schrank, Suna Chung,Joshua L. Gary, William Obremskey, Paul Edward Matuszewski,David Teague,Roman M. Natoli, Ida Leah Gitajn, Michael J. Weaver,

    Importance Previous research has suggested that intrawound vancomycin powder reduces deep surgical site infections among patients with periarticular tibial fractures at high risk of infection. It is unknown whether the addition of tobramycin powder further decreases infection rates. Objective To compare whether the combination of tobramycin plus vancomycin vs vancomycin alone delivered as intrawound powder at the time of definitive fixation reduces deep surgical site infections. Design, Setting, and Participants Open-label, assessor-masked, randomized clinical trial conducted at 39 US trauma centers. Eligible patients were adults with an operatively treated periarticular tibial fracture (either tibial plateau or pilon) who met 1 of 3 criteria for elevated infection risk. Enrollment occurred between June 18, 2021, and December 12, 2024 (final follow-up, July 15, 2025). Interventions Intrawound tobramycin (1.2 g) plus vancomycin (1.0 g) powder vs intrawound vancomycin (1.0 g) powder delivered at the time of definitive fixation. Main Outcomes and Measures The primary outcome was a deep surgical site infection requiring surgical management within 182 days of definitive fracture fixation. Secondary outcomes included deep surgical site infections with pathogens that were gram-negative only, deep surgical site infections with at least 1 pathogen that was gram-positive, deep surgical site infections with polymicrobial cultures, deep surgical site infections with negative culture results, and cellulitis or skin infections treated only with antibiotics. Results Among the 1660 participants randomized, 1528 (mean age, 47.0 [SD, 14.3] years; 603 female [39.5%]; 925 male [60.5%]) were included in the primary analysis. Deep surgical site infections occurred in 51 of 753 participants (182-day probability, 7.4%) in the tobramycin plus vancomycin group and 47 of 775 participants (182-day probability, 6.6%) in the vancomycin alone group (hazard ratio, 1.11; 95% bayesian credible interval, 0.75-1.66; posterior probability of superiority, 29.7%). The threshold required for superiority was not reached for any secondary outcome. Conclusions and Relevance Among patients with operatively treated periarticular tibial fractures at high risk of infection, adding intrawound tobramycin powder to vancomycin powder at the time of definitive fixation did not reduce deep surgical site infections compared with vancomycin powder alone. Trial Registration ClinicalTrials.gov Identifier: NCT02227446

    2026
    引用
    AI阅读
    加入学术空间
    2C42-32 Infliximab and Acute Pericarditis
    N Haque, S Daouk, V Jain

    Abstract Introduction Infliximab is a commonly used tumor necrosis factor (TNF) alpha inhibitor. Adverse reactions include reactivation of tuberculosis, serum sickness. A rare, reported complication includes pericarditis. Case Presentation A 59-year-old female with chronic respiratory failure, sarcoidosis, pulmonary hypertension presented with acute chest pain that improved when leaning forward. Laboratory results revealed elevated troponin, C-reactive protein, and brain natriuretic peptide. A chest X-ray raised concern for an enlarged cardiac contour, while an electrocardiogram showed normal sinus rhythm with low voltage. Transthoracic echocardiography demonstrated a moderate-to-large pericardial effusion with diastolic collapse of the right ventricle, and a fibrinous/inflammatory mass along the free wall. A heart catheterization did not show equalization of diastolic pressures. A pericardial window was performed to drain the fibrinous fluid and evaluate the underlying etiology. The patient was treated with nonsteroidal anti-inflammatory drugs, colchicine, and prednisone. The infectious workup, including bacterial, viral, fungal, and acid-fast bacilli (AFB) pericardial fluid cultures, was negative. Fluid cytology and a recent PET scan did not raise concerns for malignancy. Autoimmune testing revealed elevated nuclear homogenous anti-neutrophilic antibodies (ANA) with negative immunofluorescence assay, anti-histone antibodies, and myositis panel. The patient had no history of recent trauma or radiation exposure. She was discharged but readmitted due to concerns for recurrent pericarditis. Infliximab was subsequently discontinued with resultant symptomatic resolution. Discussion Infliximab is increasingly used to treat various conditions, including inflammatory bowel disease, rheumatoid arthritis, plaque psoriasis. While generally well tolerated, infliximab-induced pericarditis is a rare but recognized adverse reaction, with a reported prevalence of 0.19-0.22% in post-marketing studies. The exact incidence is unknown. The proposed mechanisms include direct cardiac toxicity, an IgE-mediated allergic response, humoral antibody activation, and a delayed cell-mediated hypersensitivity reaction, resembling serum sickness. It may be associated with the production of antinuclear antibodies (79%), double-stranded (ds) DNA antibodies (725), antihistone antibodies (17-57%), and others, developing drug-induced lupus. Onset can range from less than a month to over four years after initiation of therapy. The primary treatment is discontinuation of the drug. Clinicians should maintain a high index of suspicion for pericarditis in patients receiving infliximab and consider drug withdrawal if symptoms arise. Close monitoring for severe complications, such as pericardial effusion and systemic vasculitis, is also advised. References: Thiriveedi M, et al. J Gen Intern Med. 2021;36(7):2134-8. • Fonseca A, et al. Case Rep Pediatr. 2021;9989729. • Dipasquale V, et al. J Clin Pharm Ther. 2018;43(1):107-9. • Devasahayam J, et al. J Crohns Colitis. 2012;6(6):730-1. This abstract is funded by: none

    2026American Journal of Respiratory and Critical Care Medicine(2026)
    引用
    AI阅读
    加入学术空间
    3Beyond Valve Deployment: Real-Time Hemodynamic Optimization During the Double-Tap Technique in TAVR.
    Parasuram Krishnamoorthy, Brian Kliewer
    2026JACC Case reports(2026)
    引用
    AI阅读
    加入学术空间
    4The View from Above: Redefining Intracardiac Imaging from the Internal Jugular for Transcatheter Tricuspid Interventions
    Parasuram Krishnamoorthy, Khushboo Agarwal
    2026JACC Case reports(2026)
    引用
    AI阅读
    加入学术空间
    5Resident Education: Breastfeeding in the Newborn Period
    R. D. Cox, C. Mims

    Purpose This study evaluates the effectiveness of a structured breastfeeding education program designed for pediatric residents. Although breastfeeding provides well-documented benefits for both infants and mothers, many residents report feeling inadequately trained to address breastfeeding challenges in clinical practice. Prior literature reviews highlight the absence of a standardized curriculum in pediatric residency training. The aim is to see an improvement of pediatric resident's confidence in breastfeeding knowledge with a goal of 90% of residents being very confident or somewhat confident in their breastfeeding knowledge in the newborn period. Methods We conducted a prospective, single-group, pre- and post-intervention study of pediatric residents at a single institution. The intervention, delivered during a scheduled educational block, consisted of a lecture, case-based discussions, panel Q&A, and visual aids. The session addressed: (1) benefits of breastfeeding for both infants and mothers; (2) identification and management of common breastfeeding problems within the inital newborn period; (3) practical approaches for counseling and supporting families; and (4) strategies to build resident confidence in guiding care. Consent was obtained and participants completed surveys immediately before and after the session, measuring self-reported knowledge, attitudes, and perceived readiness to handle breastfeeding-related concerns. A six-month follow-up survey is planned to evaluate sustained impact on clinical practice. Results Twenty-five residents completed both pre- and post-surveys. Mean comfort scores improved significantly across all domains using a likert scale of confidence. Confidence in managing newborn breastfeeding concerns increased from 3.3 ± 1.1 pre-intervention to 4.4 ± 0.6 post-intervention (p < 0.01). Similarly, confidence in counseling a new mother to improve her infant's latch rose from 2.9 ± 1.2 to 4.4 ± 0.7 (p < 0.01). Across all measured domains, the overall mean comfort score increased from 3.4 ± 1.16 to 4.4 ± 0.8 (p < 0.001), indicating a consistent and meaningful improvement. Conclusions Breastfeeding education is a critical but often an underrepresented component of pediatric residency training. This study demonstrates that a structured, interactive program can significantly improve resident confidence in counseling families and managing common breastfeeding concerns during the newborn period. Incorporating such education into residency curricula has the potential to enhance pediatricians’ preparedness and ultimately improve breastfeeding outcomes for families.

    2026AMERICAN JOURNAL OF THE MEDICAL SCIENCES(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 484 篇论文

    合作机构(100)

    俄克拉荷马大学合作论文 22
    俄克拉荷马大学卫生科学中心合作论文 14
    Catholic Medical Center合作论文 13
    萨拉·坎农研究学院合作论文 8
    莫菲特癌症中心合作论文 8
    阿斯利康合作论文 8
    纪念斯隆凯特琳癌症中心合作论文 7
    Services Institute of Medical Sciences合作论文 7
    德克萨斯大学奥斯汀分校合作论文 7
    阿拉巴马大学伯明翰分校合作论文 6

    机构统计